GALT – galectin therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

GALT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/4

11:17 am

galt

Galectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]

Medium Report

Galectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]

Report

3/31

08:13 am

galt

Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Low Report

Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Report

3/31

08:00 am

galt

Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update

Medium Report

Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update

Report

3/17

08:29 am

galt

Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D. [Yahoo! Finance]

Medium Report

Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D. [Yahoo! Finance]

Report

3/17

08:00 am

galt

Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.

Low Report

Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.

Report

3/16

10:59 pm

galt

Galectin Therapeutics Highlights Belapectin Data in MASH Cirrhosis KOL Event, Eyes Next Steps [Yahoo! Finance]

Low Report

Galectin Therapeutics Highlights Belapectin Data in MASH Cirrhosis KOL Event, Eyes Next Steps [Yahoo! Finance]

Report

2/26

04:05 pm

galt

Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin Development Program for Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis and Portal Hypertension, on March 10, 2026 at 12:00 PM ET

Medium Report

Report

1/22

10:00 am

galt